Related Experiment Video
Updated: May 18, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Viridin analogs derived from steroidal building blocks.
Kishore Viswanathan1, Sophia N Ononye, Harold D Cooper
1Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, United States.
Researchers synthesized novel hybrid molecules inspired by natural furanosteroids viridin and wortmannin. These compounds effectively inhibit the lipid kinase Phosphoinositide 3-kinase (PI-3K) and exhibit anti-cancer properties against breast cancer cells.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Furanosteroids like viridin and wortmannin are recognized as potent inhibitors of the lipid kinase Phosphoinositide 3-kinase (PI-3K).
- Direct synthesis of complex natural product analogs from abundant steroid precursors is of significant interest.
Purpose of the Study:
- To develop a synthetic route for accessing viridin/wortmannin hybrid molecules.
- To evaluate the PI-3K inhibitory activity and electrophilic properties of the synthesized analogs.
- To assess the anti-proliferative effects of these compounds on cancer cell lines.
Main Methods:
- Synthesis of hybrid molecules utilizing readily available steroid building blocks.
- Characterization of synthesized compounds for structural integrity and chemical properties.
- In vitro assays to determine Phosphoinositide 3-kinase (PI-3K) inhibition.
- Evaluation of anti-proliferative activity against a human breast cancer cell line.
Main Results:
- Successful synthesis of novel viridin/wortmannin hybrid molecules from accessible steroid feedstocks.
- The synthesized compounds function as effective PI-3K inhibitors.
- The hybrid molecules retain crucial electrophilic properties and demonstrate anti-proliferative effects on breast cancer cells.
Conclusions:
- The developed synthetic strategy provides direct access to functional PI-3K inhibitors based on furanosteroid scaffolds.
- These novel hybrid molecules represent promising candidates for further investigation in cancer therapy, particularly for breast cancer.
- The findings highlight the potential of modifying natural product structures for therapeutic applications.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Drug Products: Biologics, Biosimilars and Interchangeables
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Drugs that Destabilize Microtubules

